Stay updated with breaking news from Andre Choulika. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Layla Richards survived with the help of genetically engineered immune cells The first person in the world to be treated with a cure for cancer was a British baby named Layla Richards. Richards had ...
CLLS earnings call for the period ending August 6, 2021.
Alliance for Cancer Gene Therapy Summit 2021 Features World Renowned Cancer Researchers Advancing Solid Tumor Breakthroughs Share Article James P. Allison, PhD, Carl H. June, MD and Siddhartha Mukherjee, MD Keynote April 29 Summit Nobel Laureate James P. Allison, PhD, Carl H. June, MD and Pulitzer-prize winning author Siddhartha Mukherjee, MD will be the keynote speakers at the virtual Alliance for Cancer Gene Therapy Summit It’s so rare to have the opportunity to hear from the world’s top cancer researchers, biotechs, investors and patients all in the same room ...
Experts to discuss advanced cancer cell and gene therapies at Summit 2021 April 29 marks a pivotal moment in cancer research when the world's brightest minds come together to discuss how to translate the success of CAR T-cell therapies for blood cancers into successful cell and gene therapies for the most complex and deadly solid tumor cancers. The scientists and companies driving the latest advances in cancer cell and gene therapy will gather online for a virtual Summit with the Alliance for Cancer Gene Therapy, who envision a cancer free future and want to change the C-word from Cancer to C...
Cellectis SA (CLLS) Q4 2020 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Cellectis SA (NASDAQ: CLLS) Operator Greetings. Welcome to the Cellectis Fourth Quarter and Full-Year 2020 Earnings Call. At this time, all participants are in a listen-only mode and a question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded. At this time, I'll turn the conference over to Simon Harnest, Chief Investment Officer. Simon, you may begin. This article...